268 related articles for article (PubMed ID: 7296551)
21. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo.
Chello PL; Sirotnak FM; Dorick DM
Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407
[No Abstract] [Full Text] [Related]
22. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
23. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
Poppitt DG; McGown AT; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
[TBL] [Abstract][Full Text] [Related]
24. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
McGown AT; Poppitt DG; Swindell R; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842
[TBL] [Abstract][Full Text] [Related]
25. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
26. Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.
Otter GM; Sirotnak FM
Cancer Chemother Pharmacol; 1994; 33(4):286-90. PubMed ID: 8281620
[TBL] [Abstract][Full Text] [Related]
27. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
28. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
Dorr RT; Alberts DS
J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
[TBL] [Abstract][Full Text] [Related]
29. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
[TBL] [Abstract][Full Text] [Related]
30. Effect of thymidine on the toxicity and antitumor activity of ftorafur.
Grossie VB; Loo TL
Cancer Treat Rep; 1981; 65(11-12):1087-91. PubMed ID: 6794908
[TBL] [Abstract][Full Text] [Related]
31. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
32. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
Grossie VB; Rosenblum MG; Loo TL
Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
Kato T; Suzumura Y
J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
[TBL] [Abstract][Full Text] [Related]
35. Rate of DNA synthesis as an indication of drug toxicity and as a guide for scheduling cancer therapy.
Wheeler GP; Alexander JA
Cancer Treat Rep; 1978 May; 62(5):755-69. PubMed ID: 657161
[TBL] [Abstract][Full Text] [Related]
36. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
Schmid FA; Hutchison DJ; Otter GM; Stock CC
Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
[TBL] [Abstract][Full Text] [Related]
37. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
[TBL] [Abstract][Full Text] [Related]
38. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
Capizzi RL
Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
[TBL] [Abstract][Full Text] [Related]
39. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
Pouillart P; Huong TH; Lhéritier J
Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
[No Abstract] [Full Text] [Related]
40. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.
Thompson J; George EO; Poquette CA; Cheshire PJ; Richmond LB; de Graaf SS; Ma M; Stewart CF; Houghton PJ
Clin Cancer Res; 1999 Nov; 5(11):3617-31. PubMed ID: 10589779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
